Friday, 5 February 2016

Corporate News Update

CAPITALSTARS

 DAILY CORPORATE NEWS


Lupin jumps as Q3 earnings give positive surprise; profit, revenue beats estimate
Shares of Lupin surged 10% to Rs1803 on NSE post Q3FY2016 results which came better than expectations.
Lupin has announced the following results for the quarter ended December 31, 2015:
Standalone (YoY)
Net Profit rose by 49.31% to Rs766.42 crore Vs Rs513.30 crore.
Total Income increased by 21.45% to Rs2922.25 crore Vs Rs2406.03 crore.

Bosch announces Q3 net profit at Rs221 crore
Bosch Q3: Net Profit at Rs221 Cr Vs Rs111 Cr (YoY)
Total Income at Rs2,698 Cr Vs Rs2,381.6 Cr (YoY)
EBITDA +52.4% at Rs347.3 Cr Vs Rs228 Cr (YoY)

Eicher Motors spurts on robust Q3 consolidated net profit
Shares of Eicher Motors surged 8% to Rs18450 on NSE post Q4FY15 results led by strong performance sustains despite Chennai floods
Eicher Motors has announced the following results for the quarter ended December 31, 2015 (YoY):
Standalone (YoY)
Net Profit rose by 97.46% to Rs245.01 crore Vs Rs124.08 crore.
Total Income increased by 56.58% to Rs1304.81 crore Vs Rs833.28 crore.

Cadila rallies on better than expected Q3 consolidated net profit
Shares of Cadila Healthcare rallied 5% to Rs327 on NSE post better than expected Q3FY2016 results.
Cadila Healthcare has announced the following Q3 results for the quarter ended December 31, 2015 (YoY):
Standalone (YoY)
Net Profit rose by 30% to Rs469.50 crore Vs Rs361.20 crore.
Total Income increased by 20.36% to Rs1775.50 crore Vs Rs1475.10 crore.

Torrent Pharma gains on strong Q3 performance
Shares of Torrent Pharma gained over 2% to Rs1371.90 on NSE led by strong Q3 performance; upgrade to BUY with PT of Rs1, 741
Result Synopsis: Sales for the quarter reported growth of 33.1% to Rs 1539 crores; operating profit grew by 155.4% to Rs 613 crores; operating profit margin improved by 1698bps to 31.4% and profit for the quarter grew by 189.2% to Rs483 crore.
Strong performance driven mainly by US: For Q3FY2016, Torrent Pharmaceuticals (Torrent Pharma) results were ahead of expectation largely due to higher-than-expected revenues from its launches like gAbilify, gDetrol LA, gNexium and gNamenda in USA (up 226% YoY).

Related Posts:

  • Corporate News Update CAPITALSTARS  DAILY CORPORATE NEWS Team Lease Rs423 cr IPO oversubscribed The initial public offer ( IPO) of Team Lease Services has been oversubscribed by 1.83 times till afternoon on the last day of the offer … Read More
  • MCX Bullion News Updates Gold prices-Gold prices dipped slightly in early Asia on Thursday as investors looked ahead to the end of the week U.S. jobs report for fresh direction after an overnight surge. Further signs of subdued growth in the econom… Read More
  • INDIAN BENCHMARKS MARKET WRAP-UP UPDATES INDIAN BENCHMARKS: SENSEX BREAKS LOOSING STREAK UP 115 POINTS, NIFTY HOLDS 7400 The domestic equity market breached a three-day losing streak and notched up handsome gains on Thursday after a bounce in crude oil prices… Read More
  • Performance Of The Day CS PERFORMANCE MESSAGE: STOCK FUTURES: FUTURES INTRADAY: WOCKPHARMA FUTURE  SELL CALL 3  TG  CEAT LTD  FUTURE SELL CALL 3 TG  ZEEL  FUTURE SELL  CALL 3 TG   BEML FUTURE SELL… Read More
  • INDIAN BENCHMARKS NEWS UPDATES INDIAN BENCHMARKS may open flat, with a positive bias on Friday tracking a mixed trend in stock markets across Asia as traders awaited the crucial US January jobs data set for release today which may offer further cues … Read More

0 comments:

Post a Comment

Blog Archive

Powered by Blogger.